FDA leans toward authorizing Moderna booster at a half dose3 min read . Updated: 29 Sep 2021, 08:42 PM IST
Proceeding with a 50-microgram dose could reduce the risk of side effects from a booster, and would also allow Moderna to produce more doses globally in the near-term
The US Food and Drug Administration is leaning toward authorizing half-dose booster shots of the Moderna Inc. coronavirus vaccine, satisfied that it’s effective in shoring up protection, people familiar with the matter said.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more